Применение искусственного интеллекта в диагностике и лечении гормональных нарушений у женщин в репродуктивном периоде

1. Андреева Е.Н., Шереметьева Е.В., Григорян О.Р. Гиперпролактинемия у женщин репродуктивного возраста: что должен помнить врач. Акушерство и гинекология. 2021; 9: 204-10. https://dx.doi.org/10.18565/aig.2021.9.204-210 [Andreeva E.N., Sheremetyeva E.V., Grigoryan O.R. Hyperprolactinemia in reproductive-aged women: what should a physician remember. Obstetrics and Gynecology. 2021; (9): 204-10 (in Russian). https://dx.doi.org/10.18565/aig.2021.9.204-210].
2. Yang J., Chen C. Hormonal changes in PCOS. J. Endocrinol. 2024: 261(1): e230342. https://dx.doi.org/10.1530/JOE-23-0342
3. Иващенко К.В., Молашенко Н.В., Платонова Н.М., Рослякова А.А., Иоути В.А., Овчаров М.В., Анцупова М.А., Лапшина А.М., Бурякина С.А., Бельцевич Д.Г., Кузнецов Н.С., Андреева Е.Н., Трошина Е.А., Мельниченко Г.А. Дифференциальная диагностика гиперандрогении. Акушерство и гинекология. 2024; 10: 200-8. https://dx.doi.org/10.18565/aig.2024.152 [Ivashchenko K.V., Molashenko N.V., Platonova N.M., Roslyakova A.A., Ioutsi V.A., Ovcharov M.V., Antsupova M.A., Lapshina A.M., Buryakina S.A., Beltsevich D.G., Kuznetsov N.S., Andreeva E.N., Troshina E.A., Melnichenko G.A. Differential diagnosis of hyperandrogenism.. Obstetrics and Gynecology. 2024; (10): 200-8. https://dx.doi.org/10.18565/aig.2024.152].
4. Шорманова Л.Ж., Габдилиашимова З.Т., Хамидуллина З.Г., Ахмедьянова Г.У. Связь между гипотиреозом и гиперпролактинемией Акушерство и гинекология. 2022; 12: 46-9. https://dx.doi.org/10.18565/aig.2022.209 [Shormanova L.Zh., Gabdiliashimova Z.T., Khamidullina Z.G., Akhmediyanova G.U. Relationship between hypothyroidism and hyperprolactinemia.. Obstetrics and Gynecology. 2022; (12): 46-9 (in Russian). https://dx.doi.org/10.18565/aig.2022.209].
5. Iannone A., Carfì A., Mastrogiovanni F., Zaccaria R., Manna C. On the role of artificial intelligence in analysing oocytes during in vitro fertilisation procedures. Artificial Intelligence in Medicine. 2024; 157: 102997.
6. Poong J., Lee G.H., Huh H., Yang D.H., Ha H. Artificial intelligence in 4D flow MRI: Review of technological aspects and clinical applications. Artificial Intelligence in Medicine. 2025; 171: 103308. https://dx.doi.org/10.1016/j.artmed.2025.103308
7. Van Engelen J.E., Hoos H.H. A survey on semi-supervised learning. Machine learning. 2020; 109(2): 373-440. https://dx.doi.org/10.1007/s10994-019-05855-6
8. Ghaderzadeh M., Garavand A., Salehnasab C. Artificial intelligence in polycystic ovary syndrome: a systematic review of diagnostic and predictive applications. BMC Med. Inform. Decis. Mak. 2025; 25(1): 427. https://dx.doi.org/10.1186/s12911-025-03255-6
9. Barrera F.J., Brown E.D.L., Rojo A., Obeso J., Plata H., Lincango E.P. et al. Application of machine learning and artificial intelligence in the diagnosis and classification of polycystic ovarian syndrome: a systematic review. Front. Endocrinol. (Lausanne). 2023; 14: 1106625. https://dx.doi.org/10.3389/fendo.2023.1106625
10. Wang J., Chen R., Long H., He J., Tang M., Su M. et al. Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. Radiol. Med. 2025; 130(9): 1409-41. https://dx.doi.org/10.1007/s11547-025-02032-9
11. Bharati S., Podder P., Mondal M.R.H. Diagnosis of polycystic ovary syndrome using machine learning algorithms. 2020 IEEE region 10 symposium (TENSYMP). IEEE; 2020: 1486-9. https://dx.doi.org/10.1109/TENSYMP50017.2020.9230932
12. Tong C., Wu Y., Zhuang Z., Yu Y. A diagnostic model for polycystic ovary syndrome based on machine learning. Sci. Rep. 2025; 15(1): 9821. https://dx.doi.org/10.1038/s41598-025-92630-4
13. Tiwari S., Kane L., Koundal D., Jain A., Alhudhaif A., Polatet K. et al. SPOSDS: a smart polycystic ovary syndrome diagnostic system using machine learning. Expert Systems with Applications. 2022; 203: 117592. https://dx.doi.org/10.1016/j.eswa.2022.117592
14. Zhu Y., Luo D., Shen X., Shi Q., Lv H., Zhang S. et al. Application of ChatGPT-based artificial intelligence in the diagnosis and management of polycystic ovary syndrome. BMC Med. Inform. Decis. Mak. 2025; 25(1): 271. https://dx.doi.org/10.1186/s12911-025-03114-4
15. Ahmed S., Rahman S., Jahan I., Shamim Kaiser M., Sanwar Hosen A.S.M., Ghimire D. et al. A review on the detection techniques of polycystic ovary syndrome using machine learning. IEEE Access. 2023; 11: 86522-43. https://dx.doi.org/10.1109/ACCESS.2023.3304536
16. Arabkermani Z., Barzegari S., Rouhani A., Nahavandi N., Gibreel O., Arpaci I. Mobile apps designed for patients with polycystic ovary syndrome: content analysis using the mobile app rating scale. J. Med. Internet Res. 2025; 27: e71118. https://dx.doi.org/10.2196/71118
17. Eswaran U. Eswaran V., Murali K., Eswaran V. AI-powered personalized nutrition: How AI can customize nutrition plans based on individual PCOS profiles. In: Kumar R., Gupta M., Nayyar A., eds. AI-based nutritional intervention in polycystic ovary syndrome (PCOS). Singapore: Springer Nature Singapore; 2025: 105-40. https://dx.doi.org/10.1007/978-981-96-2120-0_4
18. Chen H., Wang Y., Xu F., Huang Z., Chen W. Patients’ experiences of telehealth-based nutrition interventions for polycystic ovary syndrome in China: qualitative descriptive study. J. Med. Internet Res. 2025; 27: e77709. https://dx.doi.org/10.2196/77709
19. Cussen L. McDonnell T., Bennett G., Thompson C.J., Sherlock M., O'Reilly M.W. Approach to androgen excess in women: clinical and biochemical insights. Clin. Endocrinol. (Oxf). 2022; 97(2): 174-86. https://dx.doi.org/10.1111/cen.14710
20. Hong N., Park H., Rhee Y. Machine learning applications in endocrinology and metabolism research: an overview. Endocrinol. Metab. (Seoul). 2020; 35(1): 71-84. https://dx.doi.org/10.3803/EnM.2020.35.1.71
21. Kamińska M., Trofimiuk-Müldner M., Sokołowski G., Hubalewska-Dydejczyk A. Machine learning in endocrinology: current applications and future perspectives. Endocrine. 2025; 90(2): 357-66. https://dx.doi.org/10.1007/s12020-025-04378-6
22. Giorgini F., Di Dalmazi G., Diciotti S. Artificial intelligence in endocrinology: a comprehensive review. J. Endocrinol. Invest. 2024; 47(5): 1067-82. https://dx.doi.org/10.1007/s40618-023-02235-9
23. Bachelot G., Bachelot A., Bonnier M., Salem J.E., Farabos D., Trabado S., Dupont C. et al. Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing. Hum. Reprod. 2023; 38(2): 266-76. https://dx.doi.org/10.1093/humrep/deac254
24. Ueland G.Å., Rinne Dahl S., Methlie P., Hessen S., Husebye E.S., Thorsby P.M. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry. Fertil. Steril. 2022; 118(2): 384-91. https://dx.doi.org/10.1016/j.fertnstert.2022.05.012
25. Seité S., Khammari A., Benzaquen M., Moyal D., Dréno B. Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs. Exp. Dermatol. 2019; 28(11): 1252-7. https://dx.doi.org/10.1111/exd.14022
26. Huynh Q.T., Nguyen P.H., Le H.X., Ngo L.T., Trinh N.T., Tran M.T. et al. Automatic acne object detection and acne severity grading using smartphone images and artificial intelligence. Diagnostics (Basel). 2022; 12(8): 1879. https://dx.doi.org/10.3390/diagnostics12081879
27. Wang J., Luo Y., Wang Z., Hounye A.H., Cao C., Hou M. et al. A cell phone app for facial acne severity assessment. Appl. Intell. (Dordr). 2023; 53(7): 7614-33. https://dx.doi.org/10.1007/s10489-022-03774-z
28. Crosby P.D.A., Rittmaster R.S. Predictors of clinical response in hirsute women treated with spironolactone. Fertil. Steril. 1991; 55(6): 1076-81. https://dx.doi.org/10.1016/s0015-0282(16)54355-6
29. Струнин Д.А. Нейросетевые технологии в медицине: диагностика и прогнозирование заболеваний. Молодой ученый. 2025; 7(558): 16-8. [Strunin D.A. Neural network technologies in medicine: diagnostics and disease prediction. Young Scientist. 2025; 7(558): 16-8 (in Russian)].
30. Yoshihara A., Yoshimura Noh J., Inoue K., Taguchi J., Hata K., Aizawa T. et al. Prediction model of Graves’ disease in general clinical practice based on complete blood count and biochemistry profile. Endocr. J. 2022; 69(9): 1091-100. https://dx.doi.org/10.1507/endocrj.EJ21-0741
31. Baek H.S., Lim D. 9176 Deep learning analysis with gray scale and doppler ultrasonography images to differentiate Graves’ disease. J. Endocr. Soc. 2024; 8(Suppl 1): bvae163.1932. https://dx.doi.org/10.1210/jendso/bvae163.1932
32. Shin K., Kim J., Park J., Oh T.J., Kong S.H., Ahn C.H. et al. A machine learning-assisted system to predict thyrotoxicosis using patients’ heart rate monitoring data: a retrospective cohort study. Sci. Rep. 2023; 13(1): 21096. https://dx.doi.org/10.1038/s41598-023-48199-x
33. Ruan T., Shao X., Sun Y., Ju X., Cui J. Evaluation of accuracy, quality, and readability of information on hypothyroidism provided by different artificial intelligence chatbot models. Front. Public Health. 2025; 13: 1698596. https://dx.doi.org/10.3389/fpubh.2025.1698596
34. Noh J.Y., Yoshihara A., Hiruma S., Ichikawa M., Hirose R., Koshibu M. et al. An evaluation of the efficacy of machine learning in predicting thyrotoxicosis and hypothyroidism: a comparative assessment of biochemical test parameters used in different health checkups. Inter. Med. 2024; 63(16): 2259-68. https://dx.doi.org/10.2169/internalmedicine.2825-23
35. Zhu X., Hu J., Xiao T., Huang S., Shang D., Wen Y. Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients. Front. Endocrinol. (Lausanne). 2022; 13: 1011492. https://dx.doi.org/10.3389/fendo.2022.1011492
36. Назарько М.Ю., Зайцев К.С., Ковалевич Л.Д., Тарбаева Н.В. Нейросетевые модели для анализа МР-изображений аденомы гипофиза. International Journal of Open Information Technologies. 2025; 13(1): 88-95. [Nazarko M.Yu., Zaitsev K.S., Kovalevich L.D., Tarbaeva N.V. Neural network models for the analysis of MRI images of pituitary adenoma. International Journal of Open Information Technologies. 2025; 13(1): 88-95 (in Russian)].
37. Fan Y., Tao C., Feng M., Guo S., Mou A., Fang H. et al. Multiparameter MRI-based clinical-radiomic model to differentiate prolactinoma from hyperprolactinemic nonfunctioning pituitary adenoma. J. Neurosurg. 2025; 144(3): 600-10. https://dx.doi.org/10.3171/2025.6.JNS25579
38. Yuan C.G., Qu H., Dai H. A semantic segmentation model for automatic precise identification of pituitary microadenomas with preoperative MRI. Neuroradiology. 2025; 67(4): 1061-70. https://dx.doi.org/10.1007/s00234-025-03599-w
39. Banskota S., Adamson D.C. Pituitary adenomas: from diagnosis to therapeutics. Biomedicines. 2021; 9(5): 494. https://dx.doi.org/10.3390/biomedicines9050494
40. Siddique K.R., Murali N.P., Khalid U., Khan N.J., Adil A., Khondakar K.R. Machine learning in prolactinoma detection: a systematic review and meta-analysis of diagnostic innovations. Discov. Appl. Sci. 2025; 7(10): 1120. https://dx.doi.org/10.1007/s42452-025-06937-y

Поступила 20.03.2026

Принята в печать 17.07.2026